Observational Safety Study in Subjects Using Levemir (Insulin Detemir) for the Treatment of Type 1 or Type 2 Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 14 Oct 2014
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms PREDICTIVE
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 08 Apr 2008 Status changed from in progress to completed, as reported in ClinicalTrials.gov.
- 13 Mar 2006 New trial record.